Botanix Pharmaceuticals (ASX:BOT) targeting skin disease 2

Botanix Pharmaceuticals (ASX:BOT) targeting skin disease



Botanix Pharmaceuticals Limited (ASX:BOT) President, Vince Ippolito, talks about interim results from the company’s BTX 1308 psoriasis phase 1b study and opportunities in global medical dermatology.

source

Leave a Comment

Your email address will not be published. Required fields are marked *

×

Hello!

Click one of our representatives below to chat on WhatsApp or send us an email to [email protected]

 

× Order Via Whatsapp?